TrialJournal of the National Cancer Institute2018

Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.

Cheyne Kurokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.